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The azoospermia factor (AZF) regions consist of three genetic domains in the long arm of the human Y chromosome referred to
as AZFa, AZFb and AZFc. These are of importance for male fertility since they are home to genes required for spermatogenesis.
In this paper a comprehensive analysis of AZF structure and gene content will be undertaken. Particular care will be given to
the molecular mechanisms underlying the spermatogenic impairment phenotypes associated to AZF deletions. Analysis of the 14
diﬀerent AZF genes or gene families argues for the existence of functional asymmetries between the determinants; while some are
prominent players in spermatogenesis, others seem to modulate more subtly the program. In this regard, evidence supporting the
notion that DDX3Y, KDM5D, RBMY1A1, DAZ, and CDY represent key AZF spermatogenic determinants will be discussed.
1. Introduction
The notion that functional determinants of spermatogenesis
map to the Y chromosome (Y) was established in the 1970s
[1]. Ever since the pioneering observation that deletions in
the long arm of the Y chromosome (Yq) could be associated
to defects in sperm production, researchers have tried to
precisely map and identify such factors. In the course of
this paper, a thorough genetic and functional analysis of the
Y regions involved in spermatogenesis will be undertaken.
These are designated as azoospermia factor (AZF) regions
and they represent an area of significant interest in the field
of human reproduction. In order to give added insight to
this topic, the present manuscript will start with a brief
overview of the major developments in the mapping of the
AZF domains.
2. Historical Perspective on theMapping of AZF
2.1. The Early Years. Following initial reports tentatively
linking the loss of genetic material in Yq to azoospermia and
hypogonadism, Tiepolo and Zuﬀardi established in 1976 the
first solid association between Y chromosome deletions and
abnormal spermatogenesis [1–4]. The authors screened 1170
infertile men for karyotypic abnormalities and observed
deletions removing both fluorescent (heterochromatic) and
nonfluorescent (euchromatic) Yq segments in 6 azoospermic
men. This association signalled the advent of a new era
in the study of the Y chromosome: the identification and
characterization of the Yq genetic determinants involved in
spermatogenesis (Figure 1). In this regard, significant eﬀorts
were invested into mapping the azoospermia factor to a
specific Yq region. These initial studies were based on the
development of linear deletion interval maps using Y-specific
DNA probes in samples from infertile men with cytoge-
netically visible Y chromosome abnormalities (illustrative
examples: [5–7]). Although Bardoni and colleagues did
manage to map the human spermatogenesis locus to a more
precise Yq interval (Yq11.23), the early deletion mapping
strategies were met with meagre success. This stemmed both
from the lack of suitable DNA markers, a consequence of
the highly repetitive organization of Yq; and a dependence
on the relatively rare occurrence of cytogenetically visible Yq
abnormalities.
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2.2. Beyond the Microscope: The Concept of Y Microdeletions.
Nevertheless, these eﬀorts were of importance in establishing
“rough drafts” of the Yq genomic map, particularly in
identifying markers to be used in subsequent projects.
Appropriately, Ma and colleagues in 1992 mapped a marker
panel consisting of 28 DNA probes using a collection of
patients with Yq structural abnormalities [8]. The real
breakthrough associated to the study was the screening of
“chromosomally normal” azoospermic men, leading to the
identification of two deletion patterns not detectable by
karyotype visualization (and therefore dubbed microdele-
tions). The implications of this result were paramount.
Firstly, it suggested that the AZF region might in fact
have a multipartite organization, with the authors refer-
ring to them as AZFa and AZFb in a subsequent report
(Figure 1) [9]. Secondly, it established the notion that
small Yq interstitial deletions not visualized in a stan-
dard karyotype analysis might be a causative agent of
spermatogenic failure. Therefore, it became evident that
the mapping of AZF could benefit from microdeletion
screening programs in infertile men with apparently normal
karyotypes.
Advances in molecular biology techniques, more specif-
ically the use of PCR-based analyses of Yq genomic markers
heralded a new stage in the quest for the AZF domains [10–
12]. Despite the failure of some early studies in confirming
the existence of two AZF regions, both the notions of multi-
ple AZF loci and of the advantages of screening karyotyp-
ically normal infertile men (not necessarily azoospermic)
gradually became entrenched in the scientific community
[13–15]. The corollary of this strategy was the screening of
370 idiopathic infertile men (either azoospermic or severe
oligozoospermic) with a marker panel consisting of 76
Yq sequence-tagged sites (STSs), most of them previously
mapped by Vollrath and colleagues in 1992 [16]. The use of a
large cohort of infertile men was crucial for the identification
of less frequent microdeletion patterns that would otherwise
pass undetected. This study revealed the existence of not two
but three AZF regions (AZFa, AZFb, and AZFc) correspond-
ing to three deletion intervals, each associated to a specific
infertility phenotype (Figure 1). Therefore, the criterion for
defining the AZF regions was above all functional since it was
based on particular spermatogenic disruption phenotypes
as means to delineate genomic regions. AZFa deletions
were associated to complete absence of germ cells in the
testis tubules (Sertoli cell-only syndrome; SCOS) and AZFb
deletions to maturation arrest at the spermatocyte stage.
Contrary to the azoospermia phenotype recorded in AZFa
and AZFb deletions, AZFc deletions were shown to be
compatible with sperm production (albeit at reduced levels)
and could be transmitted to the progeny. More specifically,
AZFc deletions were associated to hypospermatogenesis
(abnormally decreased sperm production) that stemmed
from a mixed degree of germ cell atrophy in the testis tubules
[15, 17]. Although Vogt and colleagues proposed estimates
of AZF sequence length and a series of gene candidates
responsible for the AZFb and AZFc deletion phenotypes, the
exact length, structure and gene content of the three AZF
intervals would only be fully characterized in subsequent
studies. These would show that the functional partition
of AZF into three individual regions was not reflected in
structural terms, since the AZFb and AZFc sequences overlap
(Figure 1).
2.3. From Microdeletion Screening Programs to Sequencing the
Y. The concept of AZF microdeletion screening adopted by
Vogt and colleagues was taken one step further in 1997
with the analysis of infertile men irrespectively of their
spermatogenic phenotype [18]. This revealed not only that
Yq microdeletions were present in ∼7% of the infertile
population, but also, more significantly, that a considerable
variability in sperm counts was associated to such microdele-
tions. In fact, some microdeletion types were even detected in
infertile men with normal sperm concentrations. Although
it was later shown that only some partial AZF deletions
might be compatible with normozoospermia, this study
signalled the importance of a systematic screening of these
molecular defects in the infertile population. Accordingly,
AZF microdeletions are, alongside karyotype abnormalities,
the most common known genetic cause of spermatogenic
failure [19]. Pryor and colleagues also screened fertile men,
detecting microdeletions in 2% of the individuals. This led
the authors to conclude that some microdeletion patterns
correspond to Y variants devoid of any obvious phenotypical
consequences for male fertility. Thus, an adequate deletion
screening protocol should require a validated selection of
genetic markers, as well as a precise understanding of the
AZF sequence in order to rule out functionally meaningless
polymorphisms. Such degree of knowledge was dependent
on the availability of a reference sequence for the male-
specific region of the Y, which only materialized in the early
2000s [20].
After this brief overview of the historical landmarks on
the identification of AZF, the following paragraphs contain
a thorough genetic and functional characterization of the
three intervals. For an abridged analysis of the mapping and
functional properties of the AZF genes please consult Table 1
and Figure 2.
3. The AZFa Region of the Y Chromosome
The AZFa region totals 792 kb and was fully sequenced
in 1999 [21]. AZFa maps to proximal Yq (chromosome
location: ∼12.9–13.7 Mb) and unlike either AZFb or AZFc,
is exclusively constituted by single-copy DNA (Figure 2).
The region is flanked by two human endogenous retrovirus
(HERV) elements, spanning approximately 10 kb each and
displaying considerable levels of sequence identity. Although
the degree of similarity varies along the elements (with
the distal HERV copy having an additional insertion of ∼
1.5 kb of transposon material—the L1 insertion), an overall
sequence identity of 94% potentiates the occurrence of
HERV-mediated rearrangements [22]. Accordingly, the com-
plete AZFa deletion is the result of non-allelic homologous
recombination (NAHR) between the two HERV elements
[22–24]. This deletion is always associated with SCOS and is
a fairly rare event, representing less than 5% of the reported
Journal of Biomedicine and Biotechnology 3
Table 1: Functional and genomic characterization of the AZF genes.
Gene symbol Gene name
AZF location
(amplicon
unit)
mRNA
expression/protein
evidence (germ cell
type)
Protein type
Role in the male
germline
Homologous genes
(location)
USP9Y
Ubiquitin specific
peptidase 9, Y-linked
AZFa
Ubiquitous/Yes
(spermatid)
Ubiquitin-specific
protease
Involved in protein
turnover in
spermatogenesis (?)
USP9X (X chr.)
DDX3Y
DEAD
(Asp-Glu-Ala-Asp)
box polypeptide 3,
Y-linked
AZFa
Ubiquitous/Yes
(spermatogonia
only)
ATP-dependent
RNA helicase
(deduced by
similarity)
RNA metabolism in
pre-meiotic germ cells
(deduced by
similarity)
DDX3X (X chr.)
CYorf15A
CYorf15B
Chromosome Y
open reading frame
15A/B
AZFb Ubiquitous/No n/a n/a CXorf15 (X chr.)
RPS4Y2
Ribosomal protein
S4, Y-linked 2
AZFb Testis-specific/No
Ribosomal protein
subunit(deduced by
similarity)
Regulation of mRNA
binding to the
ribosome (deduced
by similarity)
RPS4Y1 (Y chr.)
RPS4X (X chr.)
EIF1AY
Eukaryotic
translation initiation
factor 1A, Y-linked
AZFb
Ubiquitous/Yes
(n/a)
Enhancer of
ribosome
dissociation and
binding (deduced by
similarity)
Regulation of
translation
initiation(deduced by
similarity)
EIF1AX (X chr.)
KDM5D
Lysine (K)-specific
demethylase 5D
AZFb
Ubiquitous/Yes
(primary
spermatocytes)
Demethylase of di-
and tri-methylated
H3K4
Chromatin
remodelling in
meiosis
KDM5C (X chr.)
XKRY
XKRY2
XK, Kell blood
group complex
subunit-related,
Y-linked/2
XKRY : AZFb
(yel3)
XKRY2:
AZFb (yel4)
Testis-specific/No
Multipass
transmembrane
protein (?)
Gamete interaction
(?)
—
HSFY1
HSFY2
Heat shock
transcription factor,
Y-linked 1/2
HSFY1: AZFb
(b5)
HSFY2: AZFb
(b6)
Testis-
predominant/Yes
(up to the
spermatid stage)
Transcription factor
Gene expression
regulation (?)
HSFX1 (X chr.)
HSFX2 (X chr.)
PRY
PRY2
PTPN13-like,
Y-linked/2
PRY : AZFb
(b1)
PRY2:
AZFb/c (b2)
Testis-specific/Yes
(in some
post-meiotic cells)
Signalling molecule
(deduced by
similarity)
Germ cell apoptosis
(?)
—
RBMY1A1
RNA binding motif
protein, Y-linked,
family 1, member
A1
6 functional
copies in
AZFb, 2 of
them in
amplicon
units (t1 and
t2)
Testis-specific/Yes
(mainly meiotic
and post-meiotic
cells)
RNA-binding
protein with protein
interaction domain
RNA splicing and
metabolism, signal
transduction and
meiotic regulation
RBMX (X chr.)
RBMXL1 (Chr. 1)
RBMXL2 (Chr. 11)
RBMXL9 (Chr.9)
BPY2
BPY2B
BPY2C
Basic charge,
Y-linked, 2 B/C
BPY2:
AZFb/c (g1)
BPY2B:
AZFb/c (g2)
BPY2C: AZFc
(g3)
Testis-specific/Yes
(all spermatogenic
stages)
Highly charged
protein
Regulation of the cyto
skeletal network (?)
—
CDY1
CDY2
Chromodomain
protein, Y-linked,
1/2
CDY1A:
AZFb/c (yel1)
CDY1B:
AZFc (yel2)
CDY2A:
AZFb (yel3)
CDY2B:
AZFb (yel4)
Testis-specific/Yes
(post-meiotic cells)
Transcriptional
co-repressor with
histone
acetyltransferase
activity
Gene expression
regulation and and
post-meiotic nuclear
remodelling
CDYL (Chr. 6)
CDYL2 (Chr. 16)
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Table 1: Continued.
Gene symbol Gene name
AZF location
(amplicon
unit)
mRNA
expression/protein
evidence (germ cell
type)
Protein type
Role in the male
germline
Homologous genes
(location)
DAZ1
DAZ2
DAZ3
DAZ4
Deleted in
azoospermia 1/2/
3/4
DAZ1:
AZFb/c (r1)
DAZ2:
AZFb/c (r2)
DAZ3: AZFc
(r3)
DAZ4: AZFc
(r4)
Testis-specific/Yes
(spermatogonia)
RNA-binding
protein with protein
interaction domain
Pre-meiotic
regulation of
transcript
transport/storage,
translation initiation
and protein
interaction
DAZL (Chr. 3)
BOLL (Chr. 2)
For appropriate references please consult the manuscript. (?):inference lacking appropriate experimental validation, n/a:not available
[1] [7] [9] [16] [43]
AZF
AZF
AZFb
AZFa
AZFc
AZFb
AZFa
AZFc
AZFb
AZFa
AZFb/c
Figure 1: Mapping the azoospermia factor (AZF) region in the human Y chromosome. Heterochromatin is depicted in grey, euchromatin in
blue and the two pseudoautosomal regions in black. Starting from the initial identification in 1976 of a genomic domain in Yq euchromatin
regulating spermatogenesis, several studies have progressively led to a more refined mapping of this determinant. In 1991 Bardoni and
colleagues mapped AZF to the distal end of Yq euchromatin, while in the next year Vogt and colleagues provided evidence for a bipartite
organization (AZFa and AZFb). A major landmark was recorded in 1996, with a large-scale deletion mapping project defining three AZF
regions (AZFa, AZFb and AZFc) based on the association of specific spermatogenic disruption phenotypes to nonoverlapping deletion
intervals. Yet, Repping and colleagues demonstrated in 2002 that the distal end of AZFb corresponded to the proximal domain of AZFc. For
complete references please consult the manuscript text.
AZF deletions [25, 26]. The low prevalence most likely stems
both from limitations of the deletion mechanism (such as
the lack of multiple homology domains and a relatively
short recombination target), and from its considerable
deleterious eﬀect on fertility. Fittingly, the corresponding
NAHR product, the AZFa duplication, is detected at a four-
fold higher frequency when compared to that of the deletion
[27].
AZFa contains two ubiquitously expressed genes with
X homologues that escape inactivation: ubiquitin specific
peptidase 9, Y-linked (USP9Y) and DEAD (Asp-Glu-Ala-
Asp) box polypeptide 3, Y-linked (DDX3Y). The precise roles
these genes play in the spermatogenic process are relatively
unknown, with most of the available data arising from the
functional characterization of partial AZFa deletions. Inter-
estingly, despite being ubiquitously expressed, the deletion of
both genes only appears to have phenotypical consequences
in the male germline, suggesting that their function is tissue-
specific and/or that the X homologues can exert a rescue
eﬀect in somatic lineages.
Journal of Biomedicine and Biotechnology 5
yel3 yel4 b5 b6 b1 t1 t2 b2 g1 r1 r2 Gr1 b3 yel1 g2 r3 r4 g3 yel2 b4 Gr2
1 Mb
100 kb
AZFa deletion = 0.8 Mb
USP9Y DDX3Y
HERVHERV
AZFa
AZFb and AZFc
P3
P2
P1
P4
P5
DYZ19
u1 u2 u3
X
K
R
Y
C
D
Y
2A
C
D
Y
2B
X
K
R
Y
2
H
SF
Y
1
H
SF
Y
2
C
Yo
rf
15
A
C
Yo
rf
15
B
K
D
M
5D
E
IF
1A
Y
R
P
S4
Y
2
R
B
M
Y
1A
1
R
B
M
Y
1A
1
R
B
M
Y
1A
1
R
B
M
Y
1A
1
P
R
Y
R
B
M
Y
1A
1
R
B
M
Y
1A
1
P
R
Y
2
B
P
Y
2
D
A
Z
1
D
A
Z
2
C
D
Y
1A
B
P
Y
2B
D
A
Z
3
D
A
Z
4
B
P
Y
2C
C
D
Y
1B
AZFb deletion = 6.23 Mb
AZFb + c deletion = 7.7 Mb
AZFc deletion = 3.5 Mb
Figure 2: Schematics on the genomic architecture and gene content of the reference AZFa, AZFb and AZFc regions of the human Y
chromosome. Central ideogram depicts the Y chromosome with the pseudoautosomal regions represented by black boxes at the tips of
the chromosome (PAR1 and PAR2, respectively), the three heterochromatic domains indicated in grey (the centromeric region, the satellite
repeat array embedded in Yq euchromatin, and the Yq heterochromatic block) and euchromatin in blue. The genomic organization of the
AZFa region is depicted in the top half of the figure. This region maps from approximately 12.9 to 13.7 Mb of the chromosome and contains
two single copy genes: USP9Y and DDX3Y (represented in scale by two oriented triangles indicating 5′-3′ polarity). AZFa is flanked by two
human endogenous retrovirus (HERV) elements that mediate the occurrence of AZFa deletions via non-allelic homologous recombination.
The genomic organization of the reference AZFb and AZFc regions, as defined by the occurrence of specific deletion patterns, are depicted
in the bottom half of the figure. AZFb maps from approximately 18 to 24.7 Mb of the chromosome and AZFc from ∼23 to ∼26.7 Mb. Both
regions feature multiple stretches of ampliconic sequences, represented by block arrows. The amplicons are divided in six colour-coded
sequence families (yellow, blue, turquoise, green, red and grey) with each unit being coded according to a binomial notation indicative of
family type and copy number [20]. The size and orientation of the arrows is representative of amplicon length and polarity, respectively. The
organization of amplicons in symmetrical arrays of contiguous repeat units (palindromes P1 to P5) is represented by large triangles. AZFb
is defined by the P5/proximal P1 deletion (yel3/yel1), and AZFc by the b2/b4 deletion. Single copy domains are depicted in white and the
DYZ19 satellite repeat in grey. The spacers between the two red amplicon clusters are identical between them. Transcription unit allocation
to these regions is observable below the architecture map. For a more precise mapping of the genetic determinants please consult Figure 3.
3.1. AZFa Gene Content
3.1.1. USP9Y. The USP9Y protein is an ubiquitin-specific
protease and member of the C19 cystein peptidase fam-
ily. These enzymes promote the intracellular cleavage of
ubiquitin molecules from ubiquitinated proteins [28, 29].
Appropriately, a role for USP9Y in the regulation of protein
turnover during spermatogenesis has been proposed [30,
31]. USP9Y shares 91% identity with its X homologue
(USP9X) suggesting that both target similar molecules and
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KDM5D
EIF1AY
RPS4Y2
CYorf15A
CYorf15B
yel3 yel4 b5 b6 b1 t1 t2 b2 g1 r1 r2 Gr1 b3 yel1 g2 r3 r4 g3 yel2 b4 Gr2
1 Mb
XKRY
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(a)
(b)
Figure 3: Mapping and sequence organization of the transcription units located in the reference AZFb and AZFc regions of the human Y
chromosome. Top schematics represent the genomic organization of the AZFb and AZFc regions, as defined by Kuroda-Kawaguchi et al.,
[65] and Repping et al., [20]. Block arrows represent amplicon units and rectangles single-copy domains. The DYZ19 heterochromatic region
is identified by a discontinuous grey rectangle. a- Single-copy transcription units. Direction of the triangles indicates the 5′-3′ orientation of
the reading frames. All these sequences map outside of the ampliconic regions. b- Multi-copy sequence families. Number of triangles per line
indicates active copy number inside each sequence family. These range from two (XKRY, CDY1, CDY2, HSFY, and PRY) to six (RBMY1A1).
All multi-copy transcription units bar four members of the RBMY1A1 family map to ampliconic domains. Pseudogenes are not depicted.
may overlap functionally [32]. Studies in murine gametoge-
nesis have shown that while USP9X expression starts as early
as in the establishment of the primordial germ cell (PGC)
population in both sexes, USP9Y only starts to be expressed
in the male germline at the spermatid stage [32, 33]. This
markedly distinct expression window hints at a temporal
constrain in the regulation of USP9Y function, a probable
consequence of its molecular targets only being present at
later spermatogenic stages. Yet, available data are inconsistent
with USP9Y being a key player in male gametogenesis.
Although USP9Y deletions were initially thought to be exclu-
sively associated to azoospermia and the cause of the AZFa
deletion phenotype, two more recent reports demonstrate
otherwise. Indeed, USP9Y deletions that are compatible with
sperm production and with natural conception have already
been identified, the latter corresponding to the complete
deletion of the gene [34, 35]. Thus, published data points
to USP9Y not being essential for male fertility, as observed
in other primate lineages where the gene became inactive
[36, 37]. Nevertheless, it is still premature to discard the
involvement of USP9Y in the epistatic regulation of male
gametogenesis [38].
3.1.2. DDX3Y. The DDX3Y protein has the hallmarks of
an ATP-dependent RNA helicase belonging to the DEAD
box protein family (characterized by the conserved motif
Asp-Glu-Ala-Asp). The exact molecular role of DDX3Y
is unknown, although the DEAD box proteins have been
implicated in several key processes of RNA metabolism
such as secondary structure alteration, splicing, spliceo-
some assembly and translation initiation [39]. DDX3Y and
its X homologue (DDX3X; 91.7% sequence identity) are
ubiquitously expressed, with expression levels peaking in
testis [40, 41]. However, the widespread presence of both
transcripts in adult tissues does not directly correlate with
actual protein expression since DDX3Y, unlike DDX3X,
is testis-specific. An additional layer of regulation can be
invoked as both genes encode for testis-specific transcripts
characterized by an overall shorter length and the presence
of extended untranslated regions (UTRs) [32, 42]. This
specificity in transcriptional profiles most likely serves to
ensure a precise expression window as DDX3Y is detected
predominantly in the cytoplasm of spermatogonia whereas
DDX3X is mainly detected in spermatids [40]. The divergent
expression window of the two genes suggests that DDX3Y
may represent a specialization of DDX3X functions for pre-
meiotic developmental stages. Yet, despite diﬀerences in cell
type expression, the molecular functions of DDX3Y and
DDX3X are probably analogous, as evidenced by functional
rescue studies in murine cell lines [41].
Taking into account data from USP9Y deletions as well
as the regulation of DDX3Y function, it is tempting to
consider that the absence of the latter is the main causative
agent for the complete AZFa deletion phenotype. However,
this hypothesis still requires the validation warranted by the
unambiguous identification of DDX3Y-specific deletions.
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4. The AZFb Region of the Y Chromosome
As previously stated, the three AZF regions were defined
on a functional basis: specific spermatogenic impairment
phenotypes associated to specific deletion patterns. It should
be noted that phenotypic specificity does not necessarily
translate into genotypical individuality, as emphatically
illustrated by the AZFb and AZFc regions. Although the
AZFb and AZFc deletion phenotypes are noticeably diﬀerent
(maturation arrest and hypospermatogenesis, respectively),
both sequences overlap in Yq (Figure 2). Actually, despite
some early sequencing eﬀorts pointing to a non-overlapping
AZFb domain spanning 3.2 Mb, the molecular breakpoint
characterization of AZFb deletions revealed not only a far
larger extension for this region but also that the distal portion
of the AZFb interval is part of AZFc [43, 44]. While several
AZFb deletion patterns have been reported [45, 46], in the
present paper the extension of this domain will be considered
that defined by Repping and colleagues in 2002 [43].
According to this definition, AZFb spans a total of 6.23 Mb
and maps to ∼18.1–24.7 Mb of the Y. AZFb contains three
single-copy regions (from the large proximal u1 domain to
the more distal and considerably shorter u2 and u3 regions),
a DYZ19 satellite repeat array (embedded in the u1 region)
and 14 multicopy sequence units (Figure 2). These units are
termed amplicons and are organized in sequence families,
with intrafamily homology levels exceeding 99%. Amplicon
families are defined by a specific colour code (yellow, blue,
turquoise, green, red or grey), with each family member
identified by a numeral. Therefore, amplicons are referred
to in an ab notation, where a represents the family colour
code and b the corresponding member number. The AZFb
amplicons are divided in 6 families and of the 14 amplicon
units, half of them (yel3, yel4, b5, b6, b1, t1, t2) are exclusive
to AZFb, with the remaining being shared with AZFc
(Figure 2). Amplicons can also be categorized by a higher-
order structural organization based on symmetrical arrays
of contiguous repeat units. Such arrays are designated as
palindromes and are defined by a symmetry axis separating
two largely identical arms constituted by single or multiple
amplicon sets. AZFb contains palindromes P2 to P5, as well
as the proximal part of P1. Indeed, the first description
of AZFb deletions used palindrome notations to identify
the NAHR recombination targets giving rise to the deletion
pattern [43]. According to such notation, the complete
AZFb deletion (P5/proximal P1) corresponds to the interval
encompassed between amplicons yel3 and yel1.
The presence of extensive ampliconic domains in AZFb
makes for very peculiar rearrangement dynamics. The
complete AZFb deletion seems to occur at a similar or
slightly increased rate to that of AZFa (∼3 to 10 % of all
Yq microdeletions), despite a much larger recombination
target [47–49]. This result is somewhat counter-intuitive
if we consider recombination target length as the main
factor driving NAHR frequency. Nevertheless, this figure may
rise five-fold if AZFb+c deletions are included, suggesting
that the propensity for rearrangements may vary between
amplicon units. Regarding the spermatogenic impairment
phenotype of the complete AZFb deletion, patients are
azoospermic with testicular analysis revealing the presence
of arrested germ cells. This maturation arrest is usually at the
spermatocyte/spermatid stage, yet some very rare instances
of complete spermatogenesis in a small number of testis
tubules have been reported [47, 48]. Thus, the chances of
finding sperm in the testis of these patients are extremely
remote.
The AZFb gene content reflects the mesh of diﬀer-
ent sequence types constituting this region, with single-
copy genes mapping alongside ampliconic gene families
(Figure 3). A total of 5 diﬀerent single-copy transcription
units map to AZFb: KDM5D [lysine (K)-specific demethy-
lase 5D], EIF1AY (eukaryotic translation initiation factor
1A, Y-linked), RPS4Y2 (ribosomal protein S4, Y-linked 2),
CYorf15A (chromosome Y open reading frame 15A) and
CYorf15B (chromosome Y open reading frame 15B) [20, 43,
44]. Despite several eﬀorts to assess their functional and
regulatory properties, as a whole they can be considered as
still poorly characterized.
4.1. Single Copy AZFb Genes
4.1.1. CYorf15. The CYorf15A and CYorf15B sequences have
an X homologue (CXorf15) that belongs to the taxilin
family and has been linked to transcriptional regulation in
osteoblasts [50]. Yet, the role of CYorf15 sequences for either
general or reproductive functions is unknown. Although
CYorf15A and CYorf15B apparently encode for proteins
homologous to the amino and carboxy-terminal domains
of CXorf15, respectively, evidence for their existence is
restricted to the identification of ubiquitously expressed
transcripts [20].
4.1.2. RPS4Y2. RPS4Y2 corresponds to a fairly recent dupli-
cation of the RPS4Y gene, the latter encoding for a ribosomal
protein subunit required for mRNA binding to the ribosome
[51]. Since RPS4Y2 expression is testis-specific, a putative
role in the posttranscriptional regulation of the spermato-
genic program can be postulated [52]. Indeed, evidence for
positive selection in the RPS4Y2 coding sequence suggests a
hypothetical acquisition of germline-specific functions. Yet,
confirmation of both the existence and functional properties
of the RPS4Y2 protein are prerequisites for any further
developments.
4.1.3. EIF1AY. EIF1AY is a ubiquitously expressed Y-linked
member of the EIF-1A family—a sequence family involved in
translation initiation [53]. The EIF-1A proteins are required
for a high rate of protein biosynthesis since they enhance
ribosome dissociation into subunits and stabilize the binding
of the 43S complex (a 40S subunit, eIF2/GTP/Met-tRNAi
and eIF3) to the 5′ end of capped RNA [54]. EIF1AY has
an X-homologue (EIF1AX) and although evidence at the
protein level is available, its functions are largely deduced
by similarity to EIF1AX. In this regard, the acquisition
of male-specific regulatory features by EIF1AY and/or the
existence of partial functional overlap with EIF1AX are valid
hypotheses.
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4.1.4. KDM5D. KDM5D encodes for a histone H3 lysine
4 (H3K4) demethylase that forms a protein complex with
the MSH5 DNA repair factor during spermatogenesis [55,
56]. This complex locates to condensed DNA during
the leptotene/zygotene stage, suggesting an involvement in
male germ cell chromatin remodelling. In accordance, by
demethylating di- and tri-methylated H3K4, KDM5D may
be involved in chromosome condensation during meiosis.
Such possibility fits with the instances of maturation arrest at
the spermatocyte stage associated to AZFb deletions. Despite
the apparently male germline-specific functions, this gene is
ubiquitously expressed and is homologous to KDM5C, an X-
borne gene associated to X-linked mental retardation [57–
60].
4.2. Multicopy AZFb Genes. Due to the presence of ampli-
conic sequences AZFb contains a set of 7 diﬀerent multi-
copy gene families: XKRY (XK, Kell blood group complex
subunit-related, Y-linked), HSFY (heat shock transcription
factor, Y-linked), RBMY1A1 (RNA binding motif protein,
Y-linked, family 1, member A1), PRY (PTPN13-like, Y-
linked) CDY (chromodomain protein, Y-linked), BPY2
(basic charge, Y-linked, 2), and DAZ (deleted in azoosper-
mia). The members of these gene families make for a total of
20 transcription units in the reference AZFb sequence. Since
several of them also map to AZFc, only genes with functional
copies exclusively located in AZFb will be analysed in this
section.
4.2.1. XKRY. The XKRY gene is expressed specifically in
testis and maps to the yellow-coded amplicon family.
Although protein evidence is still lacking, sequence analysis
suggests that the two active copies of XKRY (mapping to yel3
and yel4) encode for a multipass transmembrane transport
protein similar to the XK protein. The latter locates to
neuromuscular and hematopoietic cell membranes, with XK
mutations causing specific disruption phenotypes [61–63].
However, a role for XKRY in spermatogenesis has yet to be
validated despite tentative links to the fertilization process
[64].
4.2.2. HSFY. HSFY encodes for a member of the heat
shock factor family of transcriptional activators and displays
testis-predominant expression. This gene maps to the blue
amplicons with the two active copies located in b5 and
b6. HSFY is subjected to alternative splicing, generating 3
diﬀerent protein-coding transcripts with varying expression
patterns [66]. HSFY has been identified in spermatogenic
cells up to the spermatid stage and in Sertoli cells [67]. The
protein’s stage-dependent translocation from the cytoplasm
to the nucleus is suggestive of a developmentally regulated
functional window, consistent with its role as a transcrip-
tion factor. Nevertheless, as previously argued, the HSFY
polyclonal antiserum used in the former study might have
detected epitopes from the more widely expressed X homo-
logues (HSFX1/2) [32]. In this regard, a subsequent report
by the same team established that the mouse orthologue of
HSFY is predominantly expressed in round spermatids [68].
Regardless of several uncertainties on the exact function and
regulation of HSFY, a role in spermatogenesis has already
been proposed based on observations in animal models and
in infertile males. More specifically, Vinci and colleagues
detected a partial AZFb deletion purportedly only aﬀecting
the functional copies of HSFY in an azoospermic man
[69]. Yet, it should be noted that the heritability of the
deletion was unknown. More recently, HSFY protein levels in
spermatogenic cells were shown to be decreased in samples
with maturation arrest, associating once again this gene to
the regulation of male gametogenesis [70].
4.2.3. PRY. The PRY gene copies map to the blue amplicons,
with the two functional units being restricted to b1 and b2.
These are designated as PRY and PRY2, respectively, and
encode for a gene product with a low degree of similarity
to protein tyrosine phosphatase, nonreceptor type 13. The
latter corresponds to a signalling molecule involved in the
regulation of a myriad of cellular processes, particularly
in programmed cell death (illustrative example: [71]). PRY
and PRY2 display testis-specific expression and additional
regulation via alternative splicing [72]. Nevertheless, the
alternative transcript seems to correspond to a nonfunctional
isoform since it contains a premature stop codon truncating
the product at about half. The expression of PRY in germ
cells is irregular, with the protein being detected only in a
few sperm and spermatids [73]. Interestingly, both transcript
and protein levels were shown to be higher in the defective
germ cell fraction of the ejaculate. Furthermore, PRY levels
are increased in ejaculated sperm obtained from men with
abnormal semen parameters, suggesting a link between its
expression and defective spermatogenesis. Appropriately, a
role for PRY in male germ cell apoptosis has been suggested
based on the observation that approximately 40% of PRY-
positive cells show DNA fragmentation. Yet, as acknowledged
by the authors of the paper, results were insuﬃcient to fully
back the claim. Regardless of such considerations, available
evidence points to a postmeiotic expression of PRY in
restricted subsets of developing germ cells.
4.2.4. RBMY1A1. The RBMY1A1 gene family was identified
in the early 1990s [13]. At the time, the functional properties
of the then dubbed Y chromosome RNA recognition motif
gene (YRRM) made it the first candidate azoospermia factor.
Although RBMY1A1 is present in multiple copies along the
Y chromosome, the six functional units cluster to the AZFb
amplicons [74, 75]. This complex arrangement, character-
ized by an extensive array of RBMY1A1 pseudogenes and
sub-families, had thwarted initial attempts to precisely map
this determinant [76, 77]. RBMY1A1 is part of the RBM gene
family that also includes an X homologue (RBMX) and a set
of autosomal retrogene-derived copies of RBMX (of these
only RBMXL1, RBMXL2 and RBMXL9 are expressed, and
protein evidence is only available for RBMXL2) (for a review:
[78]). Unlike its ubiquitously expressed X homologue,
RBMY1A1 is expressed solely in male germ cells, with the
protein displaying a nuclear location [75]. The main feature
of the RBM family is the presence of a N-terminal RNA
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recognition motif (RRM) responsible for the interaction with
target RNA molecules [74, 79]. In this regard, RBM family
members display characteristics of canonical RNA-binding
proteins involved in nuclear RNA processing. In fact, this
gene has been linked to the storage and transport of mRNA
from the nucleus during spermatogenesis [80]. Contrasting
with the other RBM genes, RBMY1A1 also contains a C-
terminal protein interaction repeat domain enriched in
serine, arginine, glycine, and tyrosine (SRGY) [78]. This
serves as a probable regulatory region for the modulation of
RBMY1A1 function.
The nuclear localization of RBMY1A1 is pinpointed to
domains enriched in pre-mRNA splicing components, as
evidenced in prophase I nuclei [81]. In accordance, eﬀorts
to identify RBMY1A1-interacting proteins have shown that
pre-mRNA splicing regulators, particularly the SR and the
SR-related proteins, are bona fide partners [82, 83]. These
ubiquitously expressed factors also contain RRM domains,
therefore their functional modulation via RBMY1A1 inter-
action emerges as a distinct possibility [84]. Additionally,
RBMY1A1 may modulate cellular processes other than
splicing regulation and mRNA metabolism since it has been
shown to interact with the STAR and T-STAR proteins
[85]. These act not only as splicing regulators but also as
members of signal transduction pathways involved in cell
cycle control. In this regard, RBMY1A1 can be involved in
several aspects of meiotic and premeiotic regulation via the
establishment of multiple protein complexes. Interestingly,
the male germ cell-specific expression of RBMY1A1 is also
mimicked by the autosomal RBMXL2 gene. In this case the
nuclear localization of the protein during and immediately
after meiosis is suggestive of meiotic specialization [86].
In accordance, haploinsuﬃciency of the murine RBMXL2
orthologue results in abnormal spermatogenesis in animal
models [87].
The identification of the RNA targets of RBMY1A1
has been partially successful. It is believed that the RRM
domain can bind RNA at both high and low aﬃnity,
making the characterization of target molecules complex
[78]. Furthermore, the protein has an unique two-step
mechanism for RNA recognition that starts with a sequence-
specific interaction with the target molecule before eliciting a
conformational modification [88]. This complex mechanism
warrants RBMY1A1 a significant plasticity in terms of
RNA partners. Studies in murine models have identified 12
diﬀerent potential mRNA targets for RBMY1A1, most of
them expressed in testis starting from the neonatal period
[89]. Interestingly, the protein seems to be able to bind to its
own alternative transcript, suggesting a complex regulatory
network. The existence of alternative RBMY1A1 transcripts
has also been detected in humans [90].
All the aforementioned properties seem to indicate that
the disruption of RBMY1A1 plays a significant role in the
AZFb deletion phenotype. In reality, both its expression
pattern and putative role in male germ cell development
support the notion that RBMY1A1 deletions perturb the
meiotic program. Similarly, the disruption of KDM5D may
also contribute to the deletion phenotype. In fact, RBMY1A1
and KDM5D are located in the germ cell nucleus during
prophase I, suggesting involvement in meiotic orchestration.
While this regulation may be directly exerted by KDM5D
(via changes in chromatin structure), the role of RBMY1A1
might be mediated by eﬀector proteins or by transcriptional
regulation of mRNA targets.
Regardless of the actual contribution of the AZFb
genes for the maturation arrest phenotype, a predominantly
structural eﬀect of the AZFb deletion on meiotic progression
cannot be discarded. The removal of such a large stretch
of Yq chromatin (∼6.23 Mb) may result in X-Y pairing
impairment during meiosis and lead to meiotic breakdown.
This eﬀect has already been identified in patients with
AZFb+c deletions [91]. In such cases, a significant decrease
in spermatocyte X-Y bivalent formation was recorded, with
only 29% of the cells having juxtaposed telomere signals. It
can be argued that the lower rate of sex chromosome pairing
arises from DNA conformational changes that undermine
meiotic eﬃciency. However, it is impossible to dissociate the
eﬀect of gene loss from the observed pairing impairment,
particularly since we are dealing with genes involved in cell
cycle progression. Therefore, and in light of all evidence, the
maturation arrest phenotype associated to AZFb deletions
most probably stems from a combination of genetic disrup-
tion with structural defects in the chromosome.
5. The AZFc Region of the Y Chromosome
The AZFc region is one of the most remarkable domains of
the human genome, displaying a structural and functional
intricacy only paralleled by the major histocompatibility
complex in chromosome 6. The sequencing of AZFc rep-
resented a monumental eﬀort based on laborious data
compilation and inventive analytical tools [65]. Paradoxi-
cally, the eﬀort put into sequencing AZFc revealed that the
obtained sequence corresponds to just one of the plethora of
expected genomic variants in the Y chromosome population.
This observation arises from the fact that AZFc is almost
exclusively constituted by amplicons. Indeed, the extensive
homology between intra-family ampliconic units is a fertile
substrate for large-scale AZFc structural rearrangements
(deletions, duplications and inversions) as well as more
subtle sequence modifications. Yet, both the molecular
drivers and phenotypical consequences of AZFc variability
fall outside the scope of the present review, having been
thoroughly discussed elsewhere [92].
5.1. Genomic Assembly of AZFc. Approximately 95% of the
reference AZFc sequence is constituted by ampliconic units
belonging to five diﬀerent colour-coded families (blue, green,
red, grey and yellow). The remainder corresponds to a
duplicated spacer for the red amplicons (present in the
two red amplicon clusters) and a single copy domain (u3)
similar to other Y regions (Figure 2). Structurally, the region
contains one large (P1) and one smaller (P2) palindrome,
as well as the b2-u3-g1 segment. Diﬀerent models for the
genomic assembly of the reference AZFc structure have
been proposed. A simple, two-step model states that the
palindromes arose from supragenic tandem duplication
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followed by inversion [65]. Traces of such events have already
been detected in the P1 palindrome, where Alu elements
were probably involved in a large-scale duplication prior
to an IR (inverted repeat)-mediated inversion. Recently, a
more complex model for the progressive assembly of the
AZFc ampliconic organization was proposed. The model
states that 3 major waves of amplicon acquisition were
required for the establishment of AZFc, starting from a basal
structure constituted by the blue, turquoise and the distal
part of the yellow amplicons [93]. In the first wave, the
green and red amplicons were transposed; in the second the
middle segment of the yellow amplicon was acquired, and in
the third both the proximal yellow amplicon segment and
the grey amplicon were transposed. In parallel with these
acquisition waves, other molecular processes such as dele-
tions, duplications and inversions shaped AZFc by operating
on the progressively acquired blocks. A limitation to this
model is the assumption that the ampliconic families of the
ancestral AZFc state are identical to those of the reference
sequence. This limitation is also evident when calculating
the minimum-mutation history of AZFc architectures [94].
According to the most parsimonious model, the ancestral
AZFc architecture was already multicopy, with the majority
of the observed diversity arising from sequence inversions
(and to a lesser degree from deletions and duplications) in
the ancestral sequence.
In clinical terms, men with complete AZFc deletions
have variable seminal and testicular phenotypes, with sperm
production levels ranging from azoospermia to severe oligo-
zoospermia (but rarely exceeding 1 million sperm/ml) [16,
47, 48]. Although in these patients the presence of sperm in
the ejaculate is a frequent event (in ∼50 to 60% of the cases),
natural conception is extremely rare due to low sperm counts
[16, 95–101]. The variable phenotype associated to these
deletions suggests an intricate regulation of the AZFc genetic
determinants, making this region particularly prone to a
genetic background eﬀect. Complete AZFc deletions total
3.5 Mb (mapping from ∼23 to 26.8 Mb of the chromosome)
and are the product of NAHR between the b2 and b4
amplicons. They account for approximately 60% of all
recorded AZF deletions, occurring in one out of every ∼
4000 males [47, 48, 65]. The ampliconic organization of
AZFc is also responsible for partial deletions that arise from
NAHR between the more internal units. These partial AZFc
deletions are associated to extremely variable spermatogenic
disruption phenotypes (if any), leading to a debate on
whether such rearrangements represent a male infertility risk
or not (for selected reading: [92, 102, 103]).
5.2. AZFc Gene Content. As previously stated, 3 protein-
coding gene families map to the AZFc interval: BPY2,
DAZ and CDY (Figure 3). AZFc is also enriched in other
transcription units, mainly for spliced but apparently non-
coding transcripts of the TTTY family (TTTY3 and TTTY4).
Additionally, it contains an extensive array of pseudogenes.
These correspond to inactive copies of AZFb and AZFc genes
(RBMY1A1, PRY, CDY and BPY2), as well as AZFc-exclusive
sequence families [GOLGA2LY1 (golgi autoantigen, golgin
subfamily a, 2-like, Y-linked 1) and CSPG4LYP1 (chondroitin
sulfate proteoglycan 4-like, Y-linked pseudogene 1)].
5.2.1. BPY2. The BPY2 gene family maps to the green AZFc
amplicons (one active copy per amplicon), encoding for a
testis-specific highly charged protein tentatively linked to
cytoskeletal regulation in spermatogenesis [64, 104]. This
gene family is further expanded by a set of pseudogene
sequences also mapping to the green amplicons [65]. Despite
the existence of a region of homology with chromosome
8, no autosomal homologues of BPY2 have been identified
[105]. The genomic organization of the gene is quite unique
since it is constituted by nine exons but only five of which
are translated into amino-acids [106]. The BPY2 protein
displays a nuclear localization throughout all male germ cell
developmental stages, persisting even in ejaculated sperm
[107]. The exact role played by BPY2 in spermatogenesis
is unclear, with most of the available knowledge being
inferred from its protein partners. Using the yeast two-
hybrid assay BPY2 has been shown to interact with ubiquitin
protein ligase E3A (UBE3A), a widely-expressed member
of the ubiquitin protein degradation system [108]. This
interaction is mediated by the HECT domain of UBE3A.
Since UBE3A corresponds to a testis-expressed E3 ubiquitin
protein ligase (responsible for the transfer of the ubiquitin
group to the targeted substrates), BPY2 may modulate its
target specificity. Additionally, the two-hybrid assays have
also identified microtubule-associated protein 1S (MAP1S)
as an interacting protein [104]. MAP1S is a member of
the microtubule-associated proteins (MAPs) family and is
involved in microtubule binding, bundling and stabilization,
as well as in the crosslinking of microtubules with micro-
filaments [109]. Since MAP1S is predominantly expressed
in testis, a putative role of BPY2/MAP1S in the control of
the male germ cell cytoskeletal network has been proposed
[104]. The functional properties of the MAP1S complex
are regulated by changes to its heavy chain, making this
molecule a suitable target for posttranslational regulation
[109]. In this context, BPY2 emerges as a very strong
candidate regulator, possibly through an UBE3A-mediated
ubiquitinization event. Protein structure prediction models
also suggest the existence of a DNA/RNA binding domain (a
HTH-like motif) in BPY2, yet experimental validation is still
lacking [110].
The screening for BPY2 mutations in infertile males
has thus far been inconclusive, with no identifiable exon
mutations in a cohort of 106 SCOS patients [111]. Therefore,
despite suggestions that a specific promoter genotype might
be associated to spermatogenic defects [111], both BPY2
function and the phenotypical consequences associated to its
disruption remain to be elucidated.
5.2.2. CDY. The chromodomain protein family (CDY) con-
sists of two Y-encoded genes (CDY1 and CDY2) and two
autosomal copies (CDYL in chromosome 6 and CDYL2 in
chromosome 16) [112]. These genes are involved in post-
meiotic nuclear remodelling and transcriptional regulation.
The Y family members map to the yellow amplicons, with
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the CDY1 copies in AZFc (amplicons yel1 and yel2) and
the CDY2 copies in AZFb (yel3 and yel4) [44, 65]. A fairly
large number of pseudogene sequences are also scattered
throughout AZFb and AZFc. As expected, the Y-linked
copies have testis-specific expression whereas the autosomal
units display a more general expression pattern (CDYL is
even ubiquitously expressed) [64, 112]. CDY1 displays two
additional transcript variants (minor and short CDY1) with
the former showing evidence of the excision of a single intron
[112, 113]. The expression of these alternative transcripts
correlates significantly with complete spermatogenesis in
testicular samples of azoospermic men [114].
The CDY proteins are characterized by two functional
motifs: an N-terminal chromatin-binding domain (the chro-
modomain) and a C-terminal catalytic domain (responsi-
ble for the CoA-dependent acetyltransferase activity). The
chromodomain is a typical signature of proteins involved
in chromatin remodelling and gene expression regulation
[115]. Accordingly, in vitro assays have demonstrated that
recombinant CDY proteins can acetylate histone H4 (and, to
a lesser degree, H2A) [116]. Furthermore, it was established
that mouse Cdyl (mCdyl) transcript and protein levels peak
at the elongating spermatid stage, a time frame coinciding
with histone H4 hyperacetylation [116]. Given the nuclear
localization of the protein and the post-meiotic expression
window, the CDY family is considered a nuclear remodelling
factor promoting histone H4 hyperacetylation [116]. The
latter, by inducing a more relaxed chromatin configuration,
may serve as trigger for the histone-to-protamine transition
and subsequent nuclear condensation.
The function of the CDY proteins is not restricted to
histone acetylation. Studies have associated CDYL and its
paralogues to transcriptional corepressor complexes consist-
ing of multiple chromatin modifying proteins [117–119].
Accordingly, the primary function of CDYL may be that
of a transcriptional co-repressor, as observed in murine
models when histone deacetylases (HDACs) bind to its
catalytic domain [117]. The protein acquires its role in
chromatin remodelling only when HDACs are degraded
(in the elongating spermatid stage) and the CoA-binding
activity of mCdyl is activated. This fits with data obtained
from protein structure analysis indicating that the CDY
proteins do not show obvious similarities to canonical
histone acetyltransferase motifs [120]. Recently, CDY1 has
also been shown to interact with lysine 9-methylated histones
(H3K9me2 and H3K9me3), although the exact functional
role of this interaction is unknown [121]. The analysis of
such binding properties further suggests that CDYL2, not
CDYL, is the ancestor of the gene family [122].
The CDY1 and CDY2 proteins are isoforms with an
amino-acid identity of 98% and a similar expression window
[112]. This contradicts previous views that CDY2 was
required at earlier spermatogenic stages [114]. On the
other hand, the global identity score between the Y-linked
CDY proteins and CDYL is just 63%. The accelerated
protein evolution rate of the Y-borne CDY sequences seems
to suggest that these copies have evolved under positive
selection for germline specific functions [123]. Nevertheless,
identity levels are slightly higher when comparing just the
functional domains of the Y-derived and autosomal copies.
In this regard, functional complementation between CDY
genes may rescue, to some extent, the loss of the AZFb and/or
AZFc variants. Fittingly, complete AZFc deletions do not
alter H4 hyperacetylation levels in developing spermatids
when compared to those recorded in nondeleted hyposper-
matogenic men [124].
5.2.3. DAZ. The members of the DAZ gene family are
RNA binding proteins that play prominent roles in the
establishment and maintenance of the male germ line (for
selected reviews: [125, 126]). This gene family consists of
three diﬀerent genetic determinants: BOLL (bol, boule-
like), DAZL and DAZ [127]. Of these, DAZ maps to AZFc
(consequently being organized as a multi-copy gene family)
with the remaining two being single-copy autosomal genes.
Since the DAZ gene family contains the Y-borne DAZ copies,
for the sake of disambiguation the italicized reference (DAZ
genes) will refer solely to the Y determinants. The DAZ genes
are present in one copy per red AZFc amplicon, for a total
of four in the reference AZFc sequence (DAZ1 to DAZ4)
[65, 128]. The particularities of the palindromic organization
of the reference sequence results in the clustering of the DAZ
copies to two red amplicon duplets, with the more proximal
cluster containing DAZ1 and DAZ2, and the more distal
cluster DAZ3 and DAZ4. Nevertheless, variations in gene
number have been recorded among diﬀerent Y chromosomes
[129, 130]. The DAZ genes encode for four protein isoforms
varying in the number of functional domains, with the most
recent data suggesting that all four are expressed in human
testis [131]. They are expressed in spermatogonia, with the
protein displaying a cytoplasmic localization [131–134].
Historically, DAZ has been the focus of considerable
attention both for its link to Yq microdeletion phenotypes
and evolutionary origin. In fact, almost 10 years before
the sequencing of the MSY, DAZ was considered to be the
azoospermia factor [17]. This gene also corresponded to the
first reported instance of an autosome to Y transposition, an
observation that triggered the resurgence of the controversy
on the evolutionary fate of the Y chromosome. DAZ was the
result of the transposition of autosomal DAZL to Yq, with the
newly acquired sequence being subjected to several bouts of
intra-and intergenic amplification followed by degeneration
of some of the amplified exonic units [128, 135]. In
this regard, DAZ corresponds to the product of diverse
evolutionary forces that have ensured that a RNA-binding
protein could evolve in a male-specific genomic context.
The fact that its reading frame emerged unscathed from all
these intense rearrangements serves as testament of positive
selection, in opposition to previous reports suggesting a lack
of selective pressure [128, 136].
The DAZ family proteins are characterized by two
functional domains: a N-terminal RRM and a C-terminal
DAZ repeat. The number of these domains varies between
the DAZ genes and may even be polymorphic in the DAZ
copies [137]. The DAZ repeat consists of a unit of 24 amino-
acids that is involved in protein-protein interactions [126].
While the number of DAZ repeat units varies in the DAZ
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genes (8 to 24), both BOLL, and DAZL contain a single
unit. Several DAZ-interacting proteins have been identified,
most of them also displaying RNA-binding properties. In
fact, DAZAP1 (DAZ associated protein 1), PUM2 (pumilio
homolog 2), DZIP1 (DAZ interacting protein 1) and DZIP3
(DAZ interacting protein 3) are not only able to interact
with DAZ family members but also have RNA binding
activity (DZIP3 couples this function with that of an
ubiquitin protein ligase) [138–142]. Additionally, DAZAP2
(DAZ interacting protein 2) although devoid of RNA binding
properties is also a regulator of the spermatogenic program.
An interesting property of the DAZ family is that the proteins
can interact with other members in the form of homo- or
heterodimers [143]. Therefore, multiple interaction patterns
might modulate the functional status of the protein in a
stage-dependent manner.
The RNA binding properties of the DAZ family are
associated to the translational activation of developmentally
regulated transcripts. Fittingly, studies in Drosophila have
shown that bol (ortologue of BOLL) mutations diminished
the protein level of a regulated gene (twine) but not of
its mRNA [144]. These properties can be ascribed to the
RRM, an RNP-type motif with a preference for poly(U)
and poly(G) UTR sequences [145–148]. The DAZ family
proteins have only one RRM, except the DAZ1 and DAZ4
copies that contain 3 and 2, respectively. Several model-
based studies have tried to identify target mRNAs, yet the full
range of these molecules is still open for debate [145–149].
This can be illustrated by the meagre overlap of identified
candidates between the diﬀerent studies. It should be noted
that this repertoire of mRNA targets may be more extensive
in humans since murine models lack the DAZ genes. Indeed,
DAZ orthologues are absent in mammals lower than Old
World monkeys. Nevertheless, the currently available list
of purported mRNA targets shows some very interesting
associations. The majority of the identified transcripts
correspond to regulators of cell cycle progression and of
general RNA metabolism. Transcripts for genes involved in
spermiogenesis also seem to be targeted by murine Dazl,
consistent with DAZL expression during cytodiﬀerentiation
[125]. Such data, although still awaiting more extensive
validation, are indicative that the DAZ family plays an
important role in the orchestration of spermatogenesis.
Fittingly, overexpression of BOLL, DAZL and DAZ promotes
the formation of haploid cells in human embryonic stem cell
diﬀerentiation systems [150].
The molecular mechanism through which the DAZ
family exerts its control over protein expression seems to
involve the enhancement of translation initiation. A model
has been proposed based on the binding of the DAZ proteins
to the 3′UTR of target mRNAs followed by the recruitment
of poly(A)-binding proteins to the transcripts [151]. These
in turn enhance the recruitment of ribosomal subunits
and consequently the onset of translational activation.
Accordingly, a report has associated DAZL to the actively
translating ribosome fraction of testis extracts, although the
robustness of this observation has been questioned [125,
152]. Moreover, the DAZ family is also involved in the
transport and storage of transcripts [153]. This function
seems to be dependent on the dynein-dynactin complex and
leads to the storage of the molecules as transcriptionally
quiescent particles waiting for proper developmental cues
to trigger their activation. This is particularly relevant in
light of the transcriptional shutdown associated to chromatin
remodelling in spermiogenesis. On a more general note,
the DAZ family corresponds to an active regulator of
the spermatogenic program, operating at multiple levels
via mediation of transcript transport/storage, translation
initiation and protein function.
Despite the significant roles in spermatogenesis
attributed to the DAZ genes, their complete deletion is
not incompatible either with sperm production (albeit
at extremely low levels) or with rare instances of natural
conception [47, 48, 95–97]. This can be explained in part
by some functional overlap between DAZ family members.
Indeed, DAZ and DAZL share 93% similarity in the RRM
region and 80-90% in the DAZ repeat domain [125]. In
this context, the loss of the Y-borne DAZ copies may be
compensated by DAZL. This functional overlap is illustrated
by the fact that a human DAZ transgene can partially rescue
the spermatogenic impairment phenotype of Dazl-null mice
[154, 155]. Nevertheless, despite an increase in the germ cell
population and meiotic progression up to the pachytene
stage, the rescue phenotype is insuﬃcient to ensure mature
sperm production. It should be noted that not even a DAZL
transgene was able to extend the rescue eﬀect to post-meiotic
stages [155], a clear indicator that interspecies diﬀerences
played a decisive role in determining the degree of rescue.
In summary, AZFc genes play important roles for male
fertility. The majority of published studies focus on the
functional properties of CDY and DAZ. Such reports indicate
that both genes may be the main functional determinants of
the interval. Yet, the eﬀects of their deletion can presumably
be minimized by some degree of phenotypical rescue ensured
by the autosomal homologues. This might account for the
less severe spermatogenic impairment phenotype associated
to AZFc deletions when compared to those removing AZFa
or AZFb. Evidence for functionally related copies being
able to partially rescue deletion phenotypes is available
in other genomic contexts. Specifically, the dynamics of
the SMN1 and SMN2 genes (survival of motor neuron
1 and 2, respectively) in the context of spinal muscular
atrophy is a prime example [156]. Nevertheless, the still
largely uncharacterized properties of BPY2 advise some
caution on relegating this gene to a secondary role in
spermatogenesis. An additional consideration regards the
possibility of the diﬀerent copies inside each AZFc gene
family varying slightly in function. In this scenario, each
copy would contribute diﬀerently to the overall function of
the gene family, with the eﬀects of some determinants being
more decisive than others. To test this hypothesis, several
authors have suggested the study of evolutionary branches
of the Y chromosome where partial AZFc deletions have
become fixed without any apparent consequences for male
fertility [37, 157]. Although such authors argue that the
copies remaining in these chromosomes represent the key
determinants of the AZFc gene families, advances have thus
far been inconclusive. Regardless of such considerations, the
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variable levels of spermatogenic impairment observed in
AZFc deletions are a clear indicator that this region is prone
to a more pronounced phenotypical modulation than the
other two AZF intervals. In this regard, factors such as genetic
background and other epigenetic/environmental cues may
play a crucial role in defining the deletion’s outcome.
Since the complete AZFc deletion removes a still signif-
icant Yq stretch, a deleterious eﬀect on cell cycle progres-
sion arising from pairing deficiencies may be considered.
Fittingly, an association between AZFc deletions and minor
impairment of telomere clustering has been reported [91].
AZFc deletions have equally been linked to instances of
prolonged zygotene stage and reduced XY condensation
[158]. However, since the level of these disturbances is
small, their eﬀective impact on spermatogenesis is highly
speculative.
6. Final Considerations and Future Perspectives
Despite the tremendous breakthroughs recorded in the past
few years, our knowledge of AZF gene function is still
considerably limited. The reasons for this can be ascribed
to both technical issues and to the inherent complexity
of this biological system. In technical terms, the lack of
easily accessible animal models (AZF sequence architectures
are only present in some primate lineages) and of in vitro
spermatogenic cell lines introduce clear restrictions to a
faster development of the field. Additionally, the biological
properties of the AZF regions further complicate matters, as
attested by the tremendous variability associated to the AZFb
and AZFc sequences, as well as the intricate regulation of
the corresponding genetic determinants. Clearly, the future
research lines to be pursued in this field consist of the full
sequencing of AZF diversity across the Y chromosome popu-
lation and of a more in-depth functional characterization of
AZF genes. Both represent considerable challenges that will
ultimately yield benefits for a significant fraction of infertile
couples. Although it is still too premature to envisage AZF
gene therapy approaches, the identification of novel AZF
molecular disturbances and their associated phenotypes is
of clear importance for the clinical management of these
patients.
Based on the state-of-the-art discussed in this paper, the
AZF genes display considerable diﬀerences in their genomic
organization and molecular role. The available evidence indi-
cates that DDX3Y in AZFa, KDM5D and RBMY1A1 in AZFb,
and DAZ and CDY in AZFb/c represent key determinants for
spermatogenesis. Yet, the characterization of the remaining
AZF genes is still quite incipient. Thus, advances in this area
are of paramount importance for a more comprehensive
outlook on the reproductive fitness of the Y chromosome.
Appropriately, the screening of infertile males for specific
deletions or other (epi)genetic alterations in AZF may reveal
new clinically-relevant mutations. Coupling such knowledge
with functional data on the aﬀected biological processes
would translate into significant conceptual advances in male
reproductive genetics.
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